OncoTricks

Lung staging, 9th edition, and stage III in the frail patient, Oct 28, 2026

Lung staging: N2 or N3?

A man in his seventies with severe chronic obstructive pulmonary disease (COPD) has a 1.7 cm squamous cell carcinoma in the left lower lobe. On endobronchial ultrasound, the right hilar node (11R) is positive; stations 7 and 4L are negative. The tumor is small. What stage is it?

If you remember one thingIn the lung, side beats size: a positive node across the midline, even a hilar one, is N3, and N3 is stage IIIB or IIIC however small the tumor.

Concepts first

TNM
tumor, nodes, metastasis
Station
a numbered place on the node map of the IASLC (International Association for the Study of Lung Cancer)
Side
same side or other side, judged against the tumor
EBUS
endobronchial ultrasound: a needle through the airway into the node
c and p
clinical stage comes from imaging and biopsies; pathological from the resected specimen
9th edition
AJCC Version 9 for lung in the US, for cancers diagnosed from January 1, 2025
T: SIZE IN 1 CM STEPS TO 5, THEN 7 (UNCHANGED IN 9TH)T1a1 cm or lessT1bover 1 to 2 cmT1cover 2 to 3 cmT2aover 3 to 4 cmT2bover 4 to 5 cmT3over 5 to 7 cmT4over 7 cmOr a structure, whatever the size:T2main bronchus (carina spared), visceralpleura, collapse or pneumonitis to the hilumT3chest wall or parietal pleura, phrenic nerve,parietal pericardium; 2nd nodule, same lobeT4mediastinum, heart, great vessels, trachea,carina, esophagus, spine, diaphragm, recurrentlaryngeal nerve; 2nd nodule, other same-side lobe
N FOR A LEFT LOWER LOBE TUMOR, FRONT VIEWpatient's RIGHTpatient's LEFT1 low neck and supraclavicular, either sidecarinamidline:left edge of the trachea2R4R2L4L5 6below andbeside aorta7below the carina10R 11Rright hilum10L 11Lleft hilum12L to 14Linside the lungtumorN1 same-side hilum or lungN2 same-side mediastinum, or 7N3 other side, or supraclavicular5-YEAR SURVIVAL BY CLINICAL NN076%N152%N238%N325%

A node in front of the trachea is 4R.The midline is the left edge of the trachea, not its middle: right paratracheal 2R and 4R reach it, so that node is N3 for a left tumor. Survival bars: clinical N, 45,032 patients in the 9th edition database (Huang 2024). Most had surgery, so read them as the order of risk, not a number to quote to an unselected patient.

Back to the left lower lobe

1. Any metastasis outside the lung of origin (other lung, pleura, pericardium, or beyond)?Answer with PET-CT and brain MRI.
yes
Stage IV: M1a, M1b, M1c1 or M1c2
no
2. A positive node across the midline, or in the low neck (station 1: scalene or supraclavicular)?
yes
N3: IIIB with T1 to T2, IIIC with T3 to T4Our patient: 11R is a right hilar node, opposite to a left tumor.
no
3. Positive same-side mediastinal or subcarinal stations: how many?
one or more
N2a if one station, N2b if two or more
none
N1 if same-side hilar or lung nodes, otherwise N0

Our patient: T1b (over 1 to 2 cm), N3, M0. Clinical stage IIIB, in the 8th and the 9th edition alike.He is not stage I because the tumor is small, and not stage IV either: an opposite hilar node is still regional. That keeps a curative plan on the table, which is the next tab.

Why EBUS samples N3 first.The bronchoscopist goes from N3 to N2 to N1, with a fresh or rinsed needle between stations, so a needle never carries cells from a lower station into one that would raise the stage. The first positive station in that order defines the highest N.

What the 9th edition changed

8TH TO 9TH EDITION: TWO SPLITS, FOUR MOVESN2 splitsN2aone N2 stationN2btwo or morecount stations, not nodesM1c splitsM1c1many, 1 systemM1c2many systemsboth stay stage IVBStage moves8th9thT1 N1IIBIIAdownT1 N2aIIIAIIBdownT3 N2aIIIBIIIAdownT2 N2bIIIAIIIBupUnchanged: T1 N2b stays IIIA; T4 N2 stays IIIB.
M: WHERE, THEN HOW MANYM1aIVAinside the chest: other lung, pleural orpericardial nodules or malignant effusionM1bIVAone metastasis outside the chest(one lesion, one organ; or one distant node)M1c1IVBseveral metastases outside the chest,all in one organ systemM1c2IVBseveral metastases outside the chest,in two or more organ systems

Why split N2?One N2 station did better than several, in clinical and pathological staging, across histology, T category and region (Huang 2024). Stations, not nodes, because a CT cannot count nodes and a pathologist often cannot either. The subcarinal station 7 counts as one station. The T categories did not change (Van Schil 2024).

Stage groups

Stage groups, M0 (IASLC 9th edition)N0N1N2aN2bN3T1aIA1IIAIIBIIIAIIIBT1bIA2IIAIIBIIIAIIIBT1cIA3IIAIIBIIIAIIIBT2aIBIIBIIIAIIIBIIIBT2bIIAIIBIIIAIIIBIIIBT3IIBIIIAIIIAIIIBIIICT4IIIAIIIAIIIBIIIBIIICmoved down or up from the 8th editionTis: stage 0. T1mi: IA1.M1a or M1b: IVA, any T, any N. M1c1 or M1c2: IVB.

Try it: stage calculator

Starts on our patient. Change any box; ticking stations builds N for you.

Positive stations (optional)

Non-small cell and small cell lung cancer, IASLC 9th edition (AJCC Version 9). Stations 3a, 3p, 8 and 9 are left out for simplicity: on the tumor side they count as N2, and each counts as a station.

Memory hooks

Tap a card to flip it.

Check yourself

Question 1Right upper lobe adenocarcinoma, 2.5 cm. EBUS: 4R positive; 7, 4L and 10R negative. No metastasis. Stage?

T1c N2a M0, stage IIB in the 9th edition. Tempting: IIIA, which it was in the 8th. This is one of the moves.

Question 2Same patient, but 4R and 7 are both positive, with 4 positive nodes inside 4R.

Two stations: N2b. T1c N2b is IIIA, unchanged from the 8th. Tempting: counting 5 nodes. Count stations, not nodes.

Question 3Left upper lobe tumor, 3.2 cm. Stations 5 and 6 positive; 4L and 7 negative. Stage?

Two stations, so N2b: T2a N2b M0 is IIIB, the one move up (IIIA in the 8th). Double trap: 5 and 6 sit side by side and look like one group, and T2 N2 used to be IIIA.

Question 4Left upper lobe tumor, 4.5 cm, a second nodule of the same histology in the left lower lobe, nodes negative. Stage? And if the nodule were in the right lung, or there were a malignant pleural effusion instead?

Other lobe, same lung: T4 N0 M0, stage IIIA; the nodule beats the size (T2b). Other lung: M1a, IVA. Malignant effusion: also M1a, IVA, not T4.

Question 5Right lower lobe tumor, 3.5 cm, N0, one adrenal metastasis. Then: three brain metastases and nothing else. Then: brain plus liver.

Adrenal: T2a N0 M1b, IVA. Three in the brain: M1c1, IVB; tempting to call it M1b because it is one organ, but M1b means one lesion. Brain plus liver: M1c2, still IVB.

Question 6Left upper lobe tumor, 2.4 cm. EBUS: a node in front of the lower trachea is positive; 4L and 7 negative. Stage? And if the only positive node were in the right supraclavicular fossa?

A node in front of the trachea is 4R, because right paratracheal reaches the left edge of the trachea: N3 for a left tumor, T1c N3 M0, IIIB. Tempting: "midline, so same side", N2a, IIB. Right supraclavicular: also N3 (station 1, either side), still IIIB; regional, not M1b.

Sources

Retrieved from PubMed, read on Oct 28, 2026.

  1. Rami-Porta R, Nishimura KK, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer. J Thorac Oncol 2024;19:1007-1027. doi:10.1016/j.jtho.2024.02.011
  2. Huang J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol 2024;19:766-785. doi:10.1016/j.jtho.2023.10.012
  3. Fong KM, Rosenthal A, et al. The IASLC Staging Project for Lung Cancer: proposals for the revision of the M descriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol 2024;19:786-802. doi:10.1016/j.jtho.2024.01.019
  4. Van Schil PE, et al. The IASLC Lung Cancer Staging Project: proposals for the revisions of the T-descriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol 2024;19:749-765. doi:10.1016/j.jtho.2023.12.006
  5. Tsao MS, et al. The IASLC Staging Project: the database and proposal for the revision of the staging of pulmonary neuroendocrine carcinoma in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol 2025;20:856-870. doi:10.1016/j.jtho.2025.01.013